Holen Sie sich die Stockscreener-App
3.72
1.06%
-0.05
Schlusskurs vom Vortag:
$3.77
Offen:
$3.74
24-Stunden-Volumen:
140.04K
Relative Volume:
0.07
Marktkapitalisierung:
$91.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-21.14%
1M Leistung:
+26.44%
6M Leistung:
+52.87%
1J Leistung:
-66.67%
1-Tages-Spanne:
$3.72
$4.00
1-Wochen-Bereich:
$3.72
$4.8395
52-Wochen-Spanne:
$1.47
$15.49
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Firmenname
Artiva Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 267-4467
Adresse
5505 MOREHOUSE DRIVE, SAN DIEGO
Vergleichen Sie ARTV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
3.73 | 92.09M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.10 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.34 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.65 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.79 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.68 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Eingeleitet | Jefferies | Buy |
| 2024-08-13 | Eingeleitet | Needham | Buy |
| 2024-08-13 | Eingeleitet | TD Cowen | Buy |
| 2024-08-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Artiva Biotherapeutics Inc Aktie (ARTV) Neueste Nachrichten
What risks investors should watch in Artiva Biotherapeutics Inc. stockMarket Performance Report & Daily Entry Point Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosInflation Watch & Weekly Stock Breakout Alerts - newser.com
Artiva Biotherapeutics Inc. stock daily chart insightsEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Artiva Biotherapeutics to Host Webcast on Initial Safety and Translational Data for AlloNK in Autoimmune Disease Treatment - Quiver Quantitative
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK® - Yahoo Finance
Can Artiva Biotherapeutics Inc. stock resist sector downturnsPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Relative strength of Artiva Biotherapeutics Inc. in sector analysis2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flowsWeekly Trade Report & Community Consensus Picks - newser.com
Advanced analytics toolkit walkthrough for Artiva Biotherapeutics Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025Quarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock is popular among millennialsWeekly Market Summary & AI Enhanced Trading Signals - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-11-03 03:05:55 - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Identifying reversal signals in Artiva Biotherapeutics Inc.July 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Oil Prices & Fast Entry and Exit Trade Plans - newser.com
Artiva Biotherapeutics Inc. stock volume spike explained2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-11-02 01:36:46 - newser.com
Published on: 2025-11-01 12:39:19 - newser.com
Published on: 2025-11-01 06:37:19 - newser.com
Best Small Cap Stocks To ConsiderOctober 19th - MarketBeat
Artiva Biotherapeutics (NASDAQ:ARTV) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockBull Run & Free Weekly Watchlist of Top Performers - newser.com
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewswire
Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease - San Diego Business Journal
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)
Es liegen keine Finanzdaten für Artiva Biotherapeutics Inc (ARTV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):